Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study |
| |
Authors: | Akira Tamaoka Naoya Sawamura Asano Odaka Nobuhiro Suzuki Hidehiro Mizusawa Shin'ichi Shoji Hiroshi Mori |
| |
Institution: | aDepartment of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba ,Japan;bDiscovery Research Division, Takeda Chemical Industries, Tsukuba ,Japan;cDepartment of Molecular Biology, Tokyo Institute of Psychiatry, Tokyo ,Japan |
| |
Abstract: | Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car?yl termini of Aβ molecules (BA27 for Aβ 1–40 and BC05 for Aβ 1–42/43). We found that the amount of Aβ 1–40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1–42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1–42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD. |
| |
Keywords: | Alzheimer's disease Amyloid β protein Diffuse plaque Amyloid angiopathy Cerebellum Enzyme-linked immunosorbent assay Immunocytochemistry |
本文献已被 ScienceDirect 等数据库收录! |
|